Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 125.13 USD 0.29%
Market Cap: 12.4B USD

Wall Street
Price Targets

NBIX Price Targets Summary
Neurocrine Biosciences Inc

Wall Street analysts forecast NBIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NBIX is 160.68 USD with a low forecast of 116.15 USD and a high forecast of 201.6 USD.

Lowest
Price Target
116.15 USD
7% Downside
Average
Price Target
160.68 USD
28% Upside
Highest
Price Target
201.6 USD
61% Upside
Neurocrine Biosciences Inc Competitors:
Price Targets
1530
3SBio Inc
8% Downside
4597
Solasia Pharma KK
60% Upside
GRAL
Grail Inc
26% Downside
BBIO
BridgeBio Pharma Inc
54% Upside
BCRX
BioCryst Pharmaceuticals Inc
65% Upside
PRQR
ProQR Therapeutics NV
399% Upside
688331
RemeGen Co Ltd
23% Downside
086890
Isu Abxis Co Ltd
90% Upside

Revenue
Forecast

Revenue Estimate
Neurocrine Biosciences Inc

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's revenue is 30%. The projected CAGR for the next 3 years is 14%.

30%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Neurocrine Biosciences Inc

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's operating income is 24%. The projected CAGR for the next 3 years is 22%.

24%
Past Growth
22%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Neurocrine Biosciences Inc

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's net income is 18%. The projected CAGR for the next 3 years is 35%.

18%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NBIX's stock price target?
Price Target
160.68 USD

According to Wall Street analysts, the average 1-year price target for NBIX is 160.68 USD with a low forecast of 116.15 USD and a high forecast of 201.6 USD.

What is Neurocrine Biosciences Inc's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's revenue is 30%. The projected CAGR for the next 3 years is 14%.

What is Neurocrine Biosciences Inc's Operating Income forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's operating income is 24%. The projected CAGR for the next 3 years is 22%.

What is Neurocrine Biosciences Inc's Net Income forecast?
Projected CAGR
35%

For the last 13 years the compound annual growth rate for Neurocrine Biosciences Inc's net income is 18%. The projected CAGR for the next 3 years is 35%.

Back to Top